An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research

被引:107
作者
Wang, XK [1 ]
Xu, L [1 ]
机构
[1] Bristol Myers Squibb Co, Dept Thrombosis Res, Princeton, NJ 08543 USA
关键词
animal model; antithrombotic; arterial thrombosis; hemostasis; mouse;
D O I
10.1016/j.thromres.2004.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Objectives: Animal models are important tools in thrombosis research and preclinical drug development. Ferric chloride has been widely used to induce arterial thrombosis in a variety of species. However, almost all previous reports applied a very high concentration of ferric chloride (10-60%) to induce thrombus formation leading to difficulties in evaluating the efficacy of antithrombotic agents. Thus, the purpose of this study was to refine the ferric-chloride-induced thrombosis model to be better suited for thrombosis research. Methods and results: Dose-dependent study was used to identify a threshold concentration of ferric chloride sufficient for consistent occlusion (as reflected by the Doppler blood flow) of the carotid artery in C57BL/6 mice. Ferric chloride concentration at or about a threshold of 2.5% was found to be sensitive to anticoagulant (e.g., heparin) and antiplatelet (e.g., clopidogrel) agents. In contrast, the vessel rapidly occluded at or above 5% ferric chloride concentration despite pretreatment with the antithrombotic agents, even at doses that exerted maximal prolongation of tail bleeding time. Conclusions: Our study provides a simple, sensitive and highly controlled method for limiting vessel injury in mice to better detect the efficacy of antithrombotic drugs and/or evaluate therapeutic targets. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 8 条
[1]   A murine model of factor XI deficiency [J].
Gailani, D ;
Lasky, NM ;
Broze, GJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (02) :134-144
[2]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339
[3]   Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice [J].
Konstantinides, S ;
Schäfer, K ;
Thinnes, T ;
Loskutoff, DJ .
CIRCULATION, 2001, 103 (04) :576-583
[4]   RAT MODEL OF ARTERIAL THROMBOSIS INDUCED BY FERRIC-CHLORIDE [J].
KURZ, KD ;
MAIN, BW ;
SANDUSKY, GE .
THROMBOSIS RESEARCH, 1990, 60 (04) :269-280
[5]   Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents [J].
Leadley, RJ ;
Chi, LG ;
Rebello, SS ;
Gagnon, A .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 43 (02) :101-116
[6]   The effectiveness of implementing the weight-based heparin nomogram as a practice guideline [J].
Raschke, RA ;
Gollihare, B ;
Peirce, JC .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (15) :1645-1649
[7]   Variable protection of β3-integrin-deficient mice from thrombosis initiated by different mechanisms [J].
Smyth, SS ;
Reis, ED ;
Väänänen, H ;
Zhang, W ;
Coller, BS .
BLOOD, 2001, 98 (04) :1055-1062
[8]   Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance [J].
Zhu, YH ;
Carmeliet, P ;
Fay, WP .
CIRCULATION, 1999, 99 (23) :3050-3055